Bausch + Lomb Expands Eye Care Range with New Blink Eye Drops

Bausch + Lomb Corporation ( (BLCO) ) has shared an announcement.

Bausch + Lomb has launched two new products, Blink Nourish and Blink Boost lubricating eye drops, in the U.S. market. These preservative-free eye drops are designed to provide hydration and comfort for dry eyes, available at major retailers like Walmart and Amazon. Blink Nourish is enriched with vitamins and amino acids to replenish the tear film, while Blink Boost uses a pH-balanced formula to match healthy tears. This launch enhances Bausch + Lomb’s product offerings, providing more options for individuals with dry eyes, especially those with sensitivities, and potentially strengthening its market position in the eye care industry.

The most recent analyst rating on (BLCO) stock is a Buy with a $18.00 price target. To see the full list of analyst forecasts on Bausch + Lomb Corporation stock, see the BLCO Stock Forecast page.

Spark’s Take on BLCO Stock

According to Spark, TipRanks’ AI Analyst, BLCO is a Neutral.

Bausch + Lomb’s overall score reflects solid revenue growth and a strong gross margin, but significant challenges in profitability and cash flow. Technical analysis shows bearish trends, while valuation metrics indicate poor earnings performance. The earnings call provided some optimism with growth in key segments, though risks remain from Pharmaceuticals and tariff pressures.

To see Spark’s full report on BLCO stock, click here.

More about Bausch + Lomb Corporation

Bausch + Lomb is a global leader in eye health, offering a comprehensive portfolio of approximately 400 products, including contact lenses, lens care products, eye care products, ophthalmic pharmaceuticals, and surgical devices. Established in 1853, the company operates in around 100 countries and is headquartered in Vaughan, Ontario, with corporate offices in Bridgewater, New Jersey.

Average Trading Volume: 846,182

Technical Sentiment Signal: Sell

Current Market Cap: $4.05B

For an in-depth examination of BLCO stock, go to TipRanks’ Stock Analysis page.